证券代码：688758 证券简称：赛分科技 公告编号：2025-026 重要内容提示： 本次股票上市类型为首发限售股份；股票认购方式为网下，上市股数为 2,975,050股。 本次股票上市流通总数为2,975,050股。 本次股票上市流通日期为2025 年 7 月 10 日。 一、本次上市流通的限售股类型 根据中国证券监督管理委员会（以下简称"中国证监会"）于 2024 年 8 月 22 日出具的《关于同意苏州赛分科技股份有限公司首次公开发行股票注册的批复》 （证监许可〔2024〕1204 号），公司获准首次向社会公众公开发行人民币普通股（A 股）股票 4,997.5690 万股，并于 2025 年 1 月 10 日在上海证券交易所科创板上市。 公司首次公开发行股票完成后，总股本为 416,464,084 股，其中有限售条件流通 股 376,959,798 股，占公司总股本的 90.51%，无限售条件流通股 39,504,286 股， 占公司总股本的 9.49%。 本次上市流通的限售股为公司首次公开发行网下配售限售股，股份数量为 2,975,050 股，占公司总股本的比例为 0.71%。上述股份锁定期为自公司 ...

中信证券股份有限公司 关于苏州赛分科技股份有限公司 首次公开发行网下配售限售股份上市流通的核查意见 中信证券股份有限公司（以下简称"中信证券"、"保荐人"）作为苏州赛 分科技股份有限公司（以下简称"赛分科技"、"公司"）首次公开发行股票并 在科创板上市的保荐人，根据《证券发行上市保荐业务管理办法》《上海证券交 易所科创板股票上市规则》 等有关法律法规和规范性文件的要求，就赛分科技 首次公开发行网下配售限售股份上市流通的事项进行了专项核查： 一、本次上市流通的限售股类型 根据中国证券监督管理委员会（以下简称"中国证监会"）于 2024 年 8 月 22 日出具的《关于同意苏州赛分科技股份有限公司首次公开发行股票注册的批 复》（证监许可〔2024〕1204 号），公司获准首次向社会公众公开发行人民币 普通股（A 股）股票 4,997.5690 万股，并于 2025 年 1 月 10 日在上海证券交易所 科创板上市。公司首次公开发行股票完成后，总股本为 416,464,084 股，其中有 限售条件流通股 376,959,798 股，占公司总股本的 90.51%，无限售条件流通股 39,504,286 股，占公司总股 ...

Core Insights - A total of 51 new companies were listed on the Shanghai Stock Exchange, Shenzhen Stock Exchange, and Beijing Stock Exchange from January to June 2025, raising a total of 37.3 billion yuan [1] - Among these, 7 companies were listed on the Sci-Tech Innovation Board, collectively raising 5.619 billion yuan [1] Listing Details - The 7 companies that chose the first set of listing standards include: - Ying Shi Innovation (688775.SH) listed on June 11, 2025, raising 1.93807 billion yuan with underwriting fees of 158.3475 million yuan [1] - Han Bang Technology (688755.SH) listed on May 16, 2025, raising 500.94 million yuan with underwriting fees of 37.2891 million yuan [1] - Sheng Ke Nano (688757.SH) listed on March 25, 2025, raising 366.21 million yuan with underwriting fees of 43.9448 million yuan [1] - Hai Bo Si Chuang (688411.SH) listed on January 27, 2025, raising 861.1 million yuan with underwriting fees of 66.4722 million yuan [1] - Xing Fu Electronics (688545.SH) listed on January 22, 2025, raising 1.168 billion yuan with underwriting fees of 82.0755 million yuan [1] - Si Kan Technology (688583.SH) listed on January 15, 2025, raising 568.82 million yuan with underwriting fees of 46.0744 million yuan [1] - Sai Fen Technology (688758.SH) listed on January 10, 2025, raising 215.89 million yuan with underwriting fees of 25.283 million yuan [1] Listing Standards - The listing standards for the Sci-Tech Innovation Board require either: - An expected market value of no less than 1 billion yuan, positive net profits for the last two years, and a cumulative net profit of no less than 50 million yuan, or - An expected market value of no less than 1 billion yuan, positive net profit for the last year, and operating revenue of no less than 100 million yuan [1]

Group 1 - The resignation of Mr. Nie Yingqing from the board of Suzhou Saifen Technology Co., Ltd. is due to retirement, and he will no longer hold any position in the company after his resignation [1][2] - The resignation will take effect immediately upon delivery to the board and will not affect the company's daily management or operations significantly [2][3] - The company will proceed with the necessary procedures to complete the board member replacement in accordance with legal requirements [2]

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 苏州赛分科技股份有限公司（以下简称"公司"）于近日收到公司保荐人中 信证券股份有限公司（以下简称"中信证券"）出具的《关于更换保荐代表人的 函》。中信证券作为公司首次公开发行股票并在科创板上市项目（以下简称"首 发上市项目"）的保荐人和持续督导机构，原指派保荐代表人刘拓先生、李雨修 先生具体负责公司持续督导工作，法定持续督导期限至 2028 年 12 月 31 日。现 因原保荐代表人李雨修先生工作变动，不再继续担任公司首发上市项目持续督导 保荐代表人。 证券代码：688758 证券简称：赛分科技 公告编号：2025-025 苏州赛分科技股份有限公司 关于变更持续督导保荐代表人的公告 为保证公司持续督导工作的有序进行，中信证券委派郑染子女士（简历详见 附件）接替李雨修先生担任公司持续督导保荐代表人，继续履行相关职责，持续 督导期至 2028 年 12 月 31 日。本次保荐代表人变更后，公司首发上市项目持续 督导期保荐代表人为刘拓先生和郑染子女士。 公司董事会对李雨修先生在公司 ...

证券代码：688758 证券简称：赛分科技 公告编号：2025-024 苏州赛分科技股份有限公司（以下简称"公司"）董事会近期收到公司董事 聂迎庆先生提交的书面辞职报告。聂迎庆先生因退休，申请辞去公司董事职务， 辞职后聂迎庆先生将不再担任公司任何职务。根据《公司法》《公司章程》等规 定，上述辞职报告自送达董事会之日起生效。 | 聂迎庆 | | | | 姓名 | | | | --- | --- | --- | --- | --- | --- | --- | | 董事 | | | 职务 | | 离任 | | | 月 30 | 2025 年 | | 间 | | 离任时 | | | 日 月 6 | 6 2027 | | 到期日 | | 原定任期 | | | 日 | 年 9 | | | | | | | 离任 | 退休 | | 原因 | | 离任 | | | 否 | | 任职 | 股子公司 | 司及其控 | 在上市公 | 是否继续 | | 不适用 | 是 | 承诺 | 适用） 的公开 | 务（如 行完毕 | 具体职 在未履 | 是否存 | 二、董事离任对公司的影响 根据《公司法》《上海证券交易所科创板股票上市规则》《公司 ...

Core Points - The company announced a cash dividend distribution of 0.041 CNY per share, totaling approximately 17.08 million CNY based on a total share capital of 416,464,084 shares [1] - The dividend distribution plan was approved at the annual shareholders' meeting held on May 20, 2025 [1] - The relevant dates for the dividend distribution include the record date, ex-dividend date, and payment date, which are specified in the announcement [1] Dividend Distribution Details - The cash dividend of 0.041 CNY per share is inclusive of tax, and the total cash dividend payout amounts to 17,075,027.44 CNY [1] - Shareholders who hold shares for more than one year will not be subject to personal income tax on the dividend income, while those holding for one year or less will have tax calculated upon the transfer of shares [2][3] - For shareholders holding shares for one month or less, a 20% personal income tax will be applied, resulting in a net dividend of 0.0328 CNY per share after tax [3] - For qualified foreign institutional investors (QFII), a 10% withholding tax will be applied, leading to a net dividend of 0.0369 CNY per share [3][4] Taxation Policies - The company will not withhold corporate income tax for other corporate shareholders, who are responsible for their own tax payments, with a gross dividend of 0.041 CNY per share [4] - The company will distribute dividends in RMB through the China Securities Depository and Clearing Corporation Limited, Shanghai Branch, for shareholders registered on the record date [1][4] - Shareholders are advised to consult the company's securities affairs department for any inquiries regarding the dividend distribution [4]

证券代码：688758 证券简称：赛分科技 公告编号：2025-023 苏州赛分科技股份有限公司2024年年度权益分派实施公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： | 股权登记日 | 除权（息）日 | 现金红利发放日 | | --- | --- | --- | | 2025/6/12 | 2025/6/13 | 2025/6/13 | 一、 通过分配方案的股东会届次和日期 本次利润分配方案经公司2025 年 5 月 20 日的2024年年度股东会审议通过。 二、 分配方案 截至股权登记日下午上海证券交易所收市后，在中国证券登记结算有限责任公 司上海分公司（以下简称"中国结算上海分公司"）登记在册的本公司全体股东。 3. 分配方案： 本次利润分配以方案实施前的公司总股本416,464,084股为基数，每股派发现 金红利0.041元（含税），共计派发现金红利17,075,027.44元。 是否涉及差异化分红送转：否 每股分配比例 每股现金红利0.041元 相关日期 1. 发放年度：2024年年度 2. ...

Investment Rating - The report maintains a "Buy" rating for the company [3][6]. Core Views - The company has shown significant revenue growth, with a projected increase in revenue from 245 million yuan in 2023 to 669 million yuan in 2027, reflecting a compound annual growth rate (CAGR) of approximately 31.6% [5][10]. - The net profit attributable to the parent company is expected to grow from 52 million yuan in 2023 to 222 million yuan in 2027, indicating a strong growth trajectory [5][10]. - The company is experiencing a rapid increase in project numbers, particularly in the industrial purification segment, which has become a major growth driver [10]. Financial Performance Summary - Revenue for 2024 is projected at 315 million yuan, representing a year-on-year growth of 28.7% [5]. - The gross margin is expected to remain stable, with a slight decrease to 71.0% in 2024 from 71.2% in 2023 [5]. - The net profit margin is projected to increase from 21.4% in 2023 to 27.0% in 2024, reflecting improved profitability [5][10]. - The company’s earnings per share (EPS) are forecasted to rise from 0.13 yuan in 2023 to 0.53 yuan in 2027 [5][10]. Segment Performance - The industrial purification segment achieved revenue of 187 million yuan in 2024, a year-on-year increase of 49.1%, driven by growth in antibody drug products [10]. - The analysis chromatography segment generated revenue of 124 million yuan in 2024, with a stable growth rate of 7.8% [10]. - The company added 209 new pharmaceutical projects in 2024, indicating a robust pipeline for future growth [10]. Valuation Metrics - The target price for the company is set at 17.85 yuan, based on a price-to-earnings (P/E) ratio of 51 times for 2026 [3][6]. - The company’s P/E ratio is projected to decrease from 128.9 in 2023 to 30.5 in 2027, indicating improving valuation as earnings grow [5][12].

Group 1 - The company is preparing for its 2024 annual shareholders' meeting, which will be held on May 20, 2025, at the company's headquarters in Suzhou [3][6]. - The meeting will include both on-site and online voting, with specific time slots allocated for each voting method [3][5]. - The company has confirmed that the total number of shares with voting rights is 209,349,558, representing 50.2683% of the total shares [5]. Group 2 - The legal opinion confirms that the procedures for convening and holding the shareholders' meeting comply with relevant laws, regulations, and the company's articles of association [6]. - The qualifications of the attendees and the convenor of the meeting have been verified and found to be in accordance with legal requirements [5][6]. - The voting results from both the on-site and online methods were combined and confirmed to be valid, with specific resolutions passed during the meeting [6].